Adiponectin in inflammatory and immune-mediated diseases

G Fantuzzi - Cytokine, 2013 - Elsevier
Circulating levels of adiponectin (APN) are reduced in obesity and associated comorbidities,
with inflammation playing an important role in downregulating APN production. In contrast to …

[HTML][HTML] Adiponectin in inflammatory and immune-mediated diseases

G Fantuzzi - Cytokine, 2013 - ncbi.nlm.nih.gov
Circulating levels of adiponectin (APN) are reduced in obesity and associated comorbidities,
with inflammation playing an important role in downregulating APN production. In contrast to …

Adiponectin in inflammatory and immune-mediated diseases.

G Fantuzzi - 2013 - cabidigitallibrary.org
Circulating levels of adiponectin (APN) are reduced in obesity and associated comorbidities,
with inflammation playing an important role in downregulating APN production. In contrast to …

[引用][C] Adiponectin in inflammatory and immune-mediated diseases

G Fantuzzi - Cytokine, 2013 - cir.nii.ac.jp
Adiponectin in inflammatory and immune-mediated diseases | CiNii Research CiNii 国立情報学
研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …

Adiponectin in inflammatory and immune-mediated diseases.

G Fantuzzi - Cytokine, 2013 - europepmc.org
Circulating levels of adiponectin (APN) are reduced in obesity and associated comorbidities,
with inflammation playing an important role in downregulating APN production. In contrast to …

Adiponectin in inflammatory and immune-mediated diseases

G Fantuzzi - Cytokine, 2013 - infona.pl
Circulating levels of adiponectin (APN) are reduced in obesity and associated comorbidities,
with inflammation playing an important role in downregulating APN production. In contrast to …

Adiponectin in inflammatory and immune-mediated diseases

G Fantuzzi - Cytokine, 2013 - pubmed.ncbi.nlm.nih.gov
Circulating levels of adiponectin (APN) are reduced in obesity and associated comorbidities,
with inflammation playing an important role in downregulating APN production. In contrast to …